Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Accelerating occupancy recovery past 90% and compounding RevPOR increases above wage inflation across the $8,489,095,000 Senior Housing Operating portfolio, expanding cash flows towards Potential value of $82.97.
Consolidated operating margin falling below 2.0% across any 12-month period due to wage inflation.
We rate Welltower a Sell. For an ordinary investor, this means avoiding new purchases and selling existing shares because the stock price trades far above what the underlying healthcare properties are worth.
On September 21, 2026, the report was prepared at a price of $232.76. This sits 215.0% above our Fair value of $73.89 and well above our Potential value of $82.97. The market is paying 77.52 times expected earnings, pricing in aggressive growth that leaves no margin of safety.4
The primary risk to the company is caregiver wage inflation across its senior housing communities. If facility operating costs rise faster than resident rent increases, operating profit will fall from FY2025's $355,168,000. Investors would see consolidated operating margins drop below 2.0%, leaving less cash to cover $19,720,804,352 in total debt as debt is refinanced at higher interest rates.24
The strongest case for the business is accelerating occupancy and rent per room across Senior Housing Operating assets, which generated $8,489,095,000 in FY2025 revenue. As aging demographics boost demand for senior living, higher rental rates could drive consensus revenue to $16,764,843,920 by FY2027, lifting cash flow towards our Potential value of $82.97.17
Growth in the 80+ population supports sustained occupancy expansion and rental pricing power across the Senior Housing Operating segment, which delivered $8,489,095,000 in FY2025 revenue.7
Long-term triple-net leases and outpatient medical facilities contributed $1,197,042,000 and $781,932,000 in FY2025, providing stable cash flows.7
Welltower operates a premier senior housing portfolio generating $8,489,095,000 in FY2025 SHO revenue across supply-constrained markets.7
We rate Welltower a Sell because the report-date price of $232.76 trades 215.0% above our Fair value of $73.89, leaving the stock severely overvalued against property-level cash generation.
On October 24, 2025, the company acquired all of the shares of HC-One Topco Limited (“HC-One”) via a share purchase agreement. HC-One operates 282 seniors housing properties in the U.K. including owned properties and leasehold interests. Long-Term/Post-Acute Care Facilities Post-acute care is at the leading edge of reducing healthcare costs while improving quality. These high-impact centers help patients recover from illness or surgery with the goals of getting the patient home and healed faster and reducing hospital readmission rates. Its long-term/post-acute care portfolio predominantly consists of skilled nursing/post-acute care facilities where most residents require 24-hour nursing and/or medical care.
Outpatient Medical Buildings Its remaining outpatient medical portfolio, exclusive of held for sale properties, primarily consists of triple-net leased properties leased to investment grade healthcare providers. As of December 31, 2025, 66% of its portfolio included leases with full pass through of expenses to the tenant, 24% with a partial
A simultaneous shock of 100-200 bps margin contraction and rising debt refinancing rates across $19,720,804,352 of total debt would compress AFFO and reduce dividend coverage given pre-tax cost of debt of 16.84%.
Welltower possesses a narrow economic moat underpinned by efficient scale in premier metropolitan senior housing markets and established healthcare partnerships.
While high replacement costs limit new competing facilities, operational exposure to caregiver labor inflation constrains economic moat widening.
Current ROIC of 0.52% remains below the cost of equity of 8.11% and WACC of 9.01% due to recent major asset deliveries.2
None of the valuation methods used to calculate Fair value relies on a separate assumption about how long the competitive advantage lasts.
The highlighted cell is Fair value when every assumption sits at its base level ($73.89). Each row and column shows what Fair value becomes when one assumption moves.
A free-cash-flow drop test is not available in this run; use the discount-rate and terminal-growth grid as the primary valuation pressure test.
Occupancy expansion and rate increases exceeding consensus would demonstrate stronger operational leverage.
Results in line with expectations confirm that cash generation remains constrained by debt service, leaving shares overvalued relative to $73.89.
Industry capex to depreciation stands at 0.17 with capex to revenue at -12.7%, while Welltower invested $33,799,000 in FY2025 capex.4
Demographic expansion of the 80+ population drives steady occupancy gains and pricing power across senior living facilities.
Caregiver labor shortages and elevated financing costs compress facility net operating income despite constrained new construction.
With a Sell rating and the report-date price of $232.76 trading at a 215.0% premium to Fair value of $73.89, no capital allocation is warranted.4
Manage portfolio risk by avoiding equity exposure when valuation multiples trade at extreme historical premiums (77.52x forward P/E) against elevated balance sheet debt of $19,720,804,352.
The report-date price of $232.76 trades at an extreme 215.0% premium to Fair value of $73.89, offering no margin of safety.
Elevated leverage with $19,720,804,352 in debt and low initial yield relative to cost of capital make the dividend vulnerable if operating costs rise.4
Post-earnings consensus revisions lowered FY2026 EPS to $2.88 and FY2027 EPS to $3.18, signaling slowing growth momentum.1
We recommend a Sell rating on Welltower. The report-date price of $232.76 trades 215.0% above our Fair value of $73.89, driven by an unsustainable 77.52x forward P/E multiple.4
Capital preservation requires exiting equity positions, as property-level net operating income and elevated debt obligations cannot justify current market valuation.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
In a downside scenario, persistent caregiver wage inflation compresses senior housing operating margins, while higher refinancing rates on debt maturities increase interest expense. Slower resident absorption weakens net operating income, causing valuation multiples to contract sharply from elevated levels.
Senior Housing Operating revenue of $8,489,095,000 in FY2025 faces persistent caregiver wage pressure, compressing operating income below FY2025 level of $355,168,000.47
Total debt of $19,720,804,352 refinanced against a pre-tax cost of debt of 16.84% and risk-free rate of 5.01% increases annual interest expense and impairs cash flows.24
Post-event consensus lowered FY2026 diluted EPS to $2.88 and FY2027 diluted EPS to $3.18; failure to meet consensus revenue of $16,764,843,920 in FY2027 reduces cash generation.1
The five developments that would weaken our investment case.
Operating margin compression signals that facility wage increases and operational expenses outpace resident rent growth. This breaks positive operating leverage in senior housing and reduces net operating income available for debt servicing and capital returns.
Current:2.03% in FY2025
Alert ifFalls below 2.0% over two consecutive quarters
Deceleration indicates softening occupancy gains or tenant resistance to annual rent increases in key metropolitan clusters. This limits organic top-line expansion, undermining property cash flows and reducing overall return on invested capital.
Current:$8,489,095,000 FY2025 SHO revenue
Alert ifDecelerates below 3.0% annualized across two consecutive quarters
A rising cost of capital increases the hurdle rate for accretive property acquisitions and raises debt refinancing expenses across existing obligations. This compresses property-level equity yields and diminishes economic profit generation.
Current:9.01% as of September 2026
Alert ifRises above 10.5% over the next 12 months
Lower international occupancy signals weakened private-pay healthcare demand and operational headwinds across United Kingdom and Canadian facilities. This impairs geographic diversification benefits and reduces foreign currency cash contribution to consolidated operations.
Current:$1,886,954,000 UK and $668,344,000 Canada revenue in FY2025
Alert ifFalls below 80.0% over any annual reporting period
Occupancy declines in outpatient properties indicate health system tenant consolidation or lease non-renewals. This erodes the non-cyclical rental ballast that buffers operational volatility in the senior housing segment and lowers operating cash conversion.
Current:$781,932,000 FY2025 revenue
Alert ifFalls below 85.0% across two consecutive fiscal quarters
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Discount the explicit dividend path and its Gordon-growth terminal value at cost of equity.
Limitation: Terminal value is 77.5% of this model's value, above the 60% level at which the methodology flags concentration; the value leans on the years beyond the explicit forecast.
Estimate property NAV or recurring AFFO earning power, bridge for debt, and apply the stock-specific cap-rate, yield, or P/FFO assumptions.
The base path projects steady occupancy recovery across senior housing facilities, with annual resident rate increases offsetting labor expenses. Contractual rental income from triple-net and outpatient properties provides cash flow stability, leading to an intrinsic target of $73.89 representing an expected return of -68.3% with probability 60.0%.
The bull path envisions accelerating senior housing occupancy exceeding pre-pandemic peaks, coupled with double-digit RevPOR growth that drives operating margins above historical norms. Capital deployment via accretive acquisitions further enhances cash generation, yielding an intrinsic target of $82.97 and an expected return of -64.4% with probability 20.0%.
Margin compression reveals heightened labor cost friction, increasing the risk of valuation multiple derating towards fair value.
Reported earnings quality is supported by strong operating cash conversion, as operational cash flow significantly exceeds net income due to non-cash depreciation charges. However, operating margin durability remains vulnerable to facility labor cost escalation, and cash flows must increasingly support elevated debt refinancing costs.
Margin expansion reveals whether resident rate increases successfully overcome caregiver wage inflation to grow net operating income.
Revenue per occupied room expansion proves pricing power and tenant absorption capacity across prime metropolitan corridors.
Refinancing existing debt at elevated coupon rates increases annual interest expense and directly reduces cash available for distribution.
Stable international occupancy confirms private-pay resilience and sustains geographic diversification benefits across foreign operations.
High lease renewal rates in medical office buildings preserve steady contractual rental streams that buffer senior housing operational volatility.
| $3.20B |
| $4.17B |
| $4.75B |
| $6.03B |
| $8.45B |
| +27.5% |
| Gross profit | $1.93B | $2.22B | $2.53B | $3.02B | $4.18B | +21.2% |
| Operating income | $660.6M | $702.6M | $957.9M | $1.10B | $171.9M | -28.6% |
| Net income | $336.1M | $141.2M | $340.1M | $951.7M | $936.8M | +29.2% |
| EPS (diluted) | $0.78 | $0.30 | $0.66 | $1.57 | $1.39 | +15.5% |
| EBITDA | $1.71B | $2.04B | $2.40B | $2.78B | $2.31B | +7.8% |
| R&D | $0 | $0 | $0 | — | — | +11.8% |
| SG&A | $126.7M | $150.4M | $179.1M | $235.5M | $1.75B | +92.7% |
Operating cash flow was $2,881,677,000 in FY2025, exceeding net income of $936,845,000 due to $2,084,868,000 in depreciation. Free cash flow of $2,847,878,000 after capex of $33,799,000 supported dividends of $1,877,289,000.456
Welltower actively utilizes capital markets, issuing $2,609,873,000 in net debt in FY2025. Total debt of $19,720,804,352 requires ongoing market access given pre-tax cost of debt of 16.84%.
ROIC of 0.52% reflects recent asset acquisitions, trailing the 8.11% cost of equity and 9.01% WACC until properties stabilize.
ROIC trails WACC by 8.49 percentage points, indicating capital deployed in new acquisitions has yet to reach operational maturity.
FY2025 operating cash flow reached $2,881,677,000 against capex of $33,799,000, yielding $2,847,878,000 in free cash flow.
Non-cash depreciation of $2,084,868,000 shields operational cash flow, supporting dividend coverage.
Senior Housing Operating revenue generated $8,489,095,000 in FY2025 out of $8,452,996,000 total revenue.
Company performance is heavily dependent on senior housing occupancy and resident rate increases.
Triple Net and Outpatient Medical generated $1,197,042,000 and $781,932,000 in FY2025.
High-margin defensive lease income buffers operational volatility in the senior housing segment.
| Revenue | $8,452,996,000 |
|---|---|
| Cost of revenue | $4,273,941,000 |
| Gross profit | $4,179,055,000 |
| Operating expenses | $3,823,887,000 |
| Operating income | $355,168,000 |
| Non-operating items and tax | $581,677,000 |
| Net income | $936,845,000 |
| Total assets | $67,303,047,000 |
|---|---|
| Cash | $5,033,678,000 |
| Current assets | $9,912,121,000 |
| Total liabilities | $24,100,108,000 |
| Current liabilities | $1,855,679,000 |
| Shareholders’ equity | $42,939,716,000 |
| Net income | $936,845,000 |
|---|---|
| Operating inflow | $4,578,445,000 |
| Depreciation and amortization | $2,084,868,000 |
| Stock-based compensation | $1,556,732,000 |
| Operating cash flow | $2,881,677,000 |
| Operating outflow | $1,696,768,000 |
| Cash available | $15,722,288,000 |
| Beginning cash | $3,711,457,000 |
| Financing inflow | $8,999,760,000 |
| Exchange-rate effect | $129,394,000 |
| Investing outflow | $10,512,749,000 |
| Capex | $33,799,000 |
| Other investing activities | $10,478,950,000 |
| Ending cash | $5,209,539,000 |
| Investing cash flow | -$10,512,749,000 |
| Financing cash flow | $8,999,760,000 |
Point-in-time financial data used in the 2026-09-21 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $4.3B | $2.1B | $1.1B | $1.6B | $1.6B | $16.9M | $901.2M | $28.9M | — | $1.2B | — | -$183.4M | -$1.3B | — | $607.2M | $607.2M | $11.7B | 30.5% | — | 4.6% | — |
| 2017-12-31 | $4.3B | $1.7B | $522.8M | $1.4B | $1.4B | $13.5M | $921.7M | $19.1M | — | $1.3B | — | $154.6M | -$1.9B | $607.2M | $309.3M | $309.3M | $11B | 25.7% | — | 4.7% | — |
| 2018-12-31 | $4.7B | $1.9B | $805M | $1.6B | $1.6B | $7.9M | $950.5M | $27.6M | $0 | $1.3B | — | -$2.4B | $818.4M | $309.3M | $316.1M | $381.9M | $12.2B | 24.7% | — | 5.1% | — |
| 2019-12-31 | $5.1B | $2.1B | $1.2B | $1.5B | $1.5B | $15.3M | $1B | $25M | $0 | $1.4B | — | -$2B | $577.2M | $316.1M | $385.8M | $284.9M | $13.4B | 24.2% | — | 4.3% | — |
| 2020-12-31 | $4.6B | $1.5B | $978.8M | $1.4B | $1.3B | $17.5M | $1B | $28.3M | $7.7M | $1.1B | — | $2.3B | -$2.1B | $385.8M | $2B | $1.5B | $2.4B | 15.8% | — | 6.4% | — |
| 2021-12-31 | $3.2B | $1.7B | $336.1M | $1.3B | $1.3B | $19.4M | $1B | $17.8M | $0 | $1B | — | -$4.5B | $1.6B | $2B | $346.8M | $1.3B | $13.9B | 23.9% | — | 6.5% | — |
| 2022-12-31 | $4.2B | $2B | $141.2M | $1.3B | $1.3B | $30.5M | $1.3B | $26.1M | $0 | $1.1B | $371.3M | -$3.7B | $2.8B | $346.8M | $722.3M | $2.1B | $14.7B | 17.9% | — | 9.1% | — |
| 2023-12-31 | $4.8B | $2.4B | $340.1M | $1.6B | $1.6B | $50.7M | $1.4B | $37.2M | — | $1.3B | $655M | -$5.7B | $5.4B | $722.3M | $2.1B | $2B | $15.7B | 19.8% | — | 9.0% | — |
| 2024-12-31 | $6B | $2.8B | $951.7M | $2.3B | $2.2B | $58.1M | $1.6B | $75.8M | — | $1.5B | -$635.1M | -$5.5B | $4.9B | $2.1B | $3.7B | $3.5B | $15.5B | 19.0% | — | 9.8% | — |
| 2025-12-31 | $8.5B | $2.3B | $936.8M | $2.9B | $2.8B | $33.8M | $2.1B | $1.6B | — | $1.9B | $2.6B | -$10.5B | $9B | $3.7B | $5.2B | $5B | $19.2B | 4.2% | — | 8.4% | — |
Welltower Inc. (WELL) trades at 77.5x forward earnings against a peer median of 83.5x. Its EV/EBITDA of 55.1x compares with a peer median of 24.5x. The comparison uses 4 peers: Healthpeak Properties Inc., Prologis Inc., Equinix Inc. and Ventas Inc., as of 2026-09-21.
| Trend | Impact | Note |
|---|
| Aging Demographics (80+ Population Growth) | positive | Growth in the 80+ population supports multi-year demand for senior housing. |
| Healthcare Labor Cost Inflation | negative | Persistent staffing shortages elevate operating expenses across assisted living facilities. |
| Outpatient Healthcare Migration | positive | Health systems expanding outpatient networks support medical office occupancy. |
Welltower holds scale in senior housing with $8,489,095,000 in FY2025 SHO revenue, offering greater pricing leverage than peer Ventas but higher operational labor risk than outpatient peer DOC.37
| Action |
|---|
| Why |
|---|
| $73.89 or below | Re-underwrite intrinsic value | Fair value midpoint of $73.89 represents property-level NAV/AFFO parity; consider entry only after substantial valuation reset. |
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
| PLD |
| Prologis Inc. |
| $132.0B |
| 39.9x |
| 13.7x |
| 24.7x |
| 7.7% |
| 43.0% |
| EQIX | Equinix Inc. | $104.3B | 56.8x | 10.5x | 27.9x | 10.7% | 27.0% |
| VTR | Ventas Inc. | $44.6B | 110.2x | 7.0x | 24.3x | 2.0% | 14.8% |
